US Nuclear files 12b-25 delaying Q1 2026 10-Q
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
US Nuclear Corp. notified the SEC that it is unable to file its Form 10-Q for the period ended March 31, 2026 "without unreasonable effort or expense" and needs additional time to compile supporting documentation and allow its independent auditor to complete review. The company states it intends to file the Form 10-Q as soon as possible.
Insights
Timely notice filed under Rule 12b-25 citing auditor review and document compilation.
The filing identifies the procedural basis for relief under Rule 12b-25 and states the company cannot complete its Form 10-Q for the period ended March 31, 2026 "without unreasonable effort or expense." The company also states the independent registered public accounting firm must complete its review.
Key items to watch in subsequent filings include the eventual filing date of the Form 10-Q and any disclosed adjustments arising from the auditor's review. The signature block shows the notification signed by Robert Goldstein, Chief Executive Officer on May 14, 2026.
Key Figures
Key Terms
Form 12b-25 regulatory
Form 10-Q regulatory
"without unreasonable effort or expense" regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did US Nuclear (UCLE) file a Form 12b-25 for the period ended March 31, 2026?
When did US Nuclear sign the 12b-25 notification and who signed it?
Will US Nuclear (UCLE) still file the Form 10-Q?
Who can investors contact about the delay in US Nuclear’s Form 10-Q?
AI-generated analysis. How Rhea-AI works. Not financial advice.